MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Diagnostic accuracy of Progressive Supranuclear Palsy: Experience of a movement disorders center

M. Gultekin (Kayseri, Turkey)

Meeting: 2019 International Congress

Abstract Number: 881

Keywords: Parkinsonism, Progressive supranuclear palsy(PSP)

Session Information

Date: Tuesday, September 24, 2019

Session Title: Parkinsonisms and Parkinson-Plus

Session Time: 1:45pm-3:15pm

Location: Agora 3 West, Level 3

Objective: The purpose of this paper is to emphasize the importance of correct diagnosis in PSP.

Background: Progressive supranuclear palsy (PSP) is a commonly disease among Parkinson plus syndromes, and its early and accurate diagnosis is usually not possible.

Method: This study formed as retrospectively. 32 patients who were diagnosed as having PSP according to the National Institute for Neurological Disorders and Society for PSP (NINDS-SPSP) criteria  included in this study. Initial diagnosis of the patients and time course until correct diagnosis as PSP were assessed.

Results: The mean age of the patients was 65.83 years and 15 patients were female (46.8%) . Most of patients were diagnosed as Parkinson’s disease (PD) before correct diagnose.  All of the patients had supranuclear gaze palsy and postural instability. The median time from onset of symptoms to diagnosed as PSP was 4.1 years (2.4-5.9).

Conclusion: Our results suggest that the correct diagnosis of PSP has taken after several years. Diagnostic criteria should be expanded and developed for earlier recognition of PSP.

References: 1- Lang AE. Clinical heterogeneity in progressive supranuclear palsy: challenges to diagnosis, pathogenesis and future therapies. Mov Disord 2014; 29:1707-1709. 2- Respondek G, Hoglinger GU. The phenotypic spectrum of progressive supranuclear palsy. Parkinsonism Related Disord 2016; 22:34-36. 3- Hoglinger GU, Respondek G, Stamelou M et al. Movement Disorder Society-endorsed PSP Study Group. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Mov Disord 2017; 32:853-864.

To cite this abstract in AMA style:

M. Gultekin. Diagnostic accuracy of Progressive Supranuclear Palsy: Experience of a movement disorders center [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/diagnostic-accuracy-of-progressive-supranuclear-palsy-experience-of-a-movement-disorders-center/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/diagnostic-accuracy-of-progressive-supranuclear-palsy-experience-of-a-movement-disorders-center/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley